- Synthesis and biological evaluation of a biotinylated paclitaxel with an extra-long chain spacer arm
-
A biotinylated paclitaxel derivative with an extra-long chain (LC-LC-biotin) spacer arm was synthesized using an improved synthetic reaction sequence. The biotinylated paclitaxel analogue retained excellent microtubule stabilizing activity in vitro. Furth
- Lis, Lev. G.,Smart, Mary A.,Luchniak, Anna,Gupta, Mohan L.,Gurvich, Vadim J.
-
supporting information
p. 745 - 748
(2012/11/13)
-
- Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates
-
Several novel gadolinium chelates conjugated with paclitaxel, colchicine and thyroxine have been prepared as MRI contrast agents targeted to tubulin and thyroxine-binding globulin, respectively.
- Efthimiadou, Eleni K.,Katsarou, Maria E.,Fardis, Michael,Zikos, Christos,Pitsinos, Emmanuel N.,Kazantzis, Athanasios,Leondiadis, Leondios,Sagnou, Marina,Vourloumis, Dionisios
-
scheme or table
p. 6058 - 6061
(2009/07/18)
-
- Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: Evaluation of novel conjugates as cytotoxic agents
-
Sixteen different taxoid conjugates were prepared by linking various anticancer compounds, including camptothecin (CPT), epipodophyllotoxin (EP), colchicine (COL), and glycyrrhetinic acid (GA), at the 2′- or 7-position on paclitaxel (TXL, 1) through an ester, imine, amine, or amide bond. Newly synthesized conjugates were evaluated for cytotoxic activity against replication of several human tumor cell lines. Among them, TXL-CPT conjugates, 8-10, were more potent than TXL itself against the human prostate carcinoma cell line PC-3 (ED50 = 14.8, 3.1, 19.4 nM compared with 55.5 nM), and conjugate 10 was also 8-fold more active than TXL against the LN-CAP prostate cancer cell line. These compounds also possessed anti-angiogenesis ability as well as lower inhibitory effects against a normal cell line (MRC-5). Thus, conjugates 8-10 are possible antitumor drug candidates, particularly for prostate cancer.
- Nakagawa-Goto, Kyoko,Nakamura, Seikou,Bastow, Kenneth F.,Nyarko, Alexander,Peng, Chieh-Yu,Lee, Fang-Yu,Lee, Fang-Chen,Lee, Kuo-Hsiung
-
p. 2894 - 2898
(2008/02/03)
-
- Antitumor agents 216. Synthesis and evaluation of paclitaxel-camptothecin conjugates as novel cytotoxic agents
-
Five conjugates (16-20) composed of a paclitaxel and a camptothecin derivative joined by an imine linkage were synthesized and evaluated as cytotoxic agents and as inhibitors of DNA topoisomerase I. All of the conjugates were potent inhibitors of tumor cell replication with improved activity relative to camptothecin. Significantly, compounds 16-18 were more active than paclitaxel and camptothecin against HCT-8 (colon adenocarcinoma) cell replication, and the spectrum of activity was different from a simple mixture of paclitaxel and camptothecin. All of the conjugates were significantly less potent than camptothecin as inhibitors of human topoisomerase I in vitro with 16, 18, and 19 showing only marginal activity at 50 μM. Based on activity against drug-resistant cell line replication, one could conclude that the conjugates are simply acting as 'weak taxanes', but the spectrum of activity, particularly against MCF-7 and HCT-8, strongly suggests that a novel mechanism of action has been achieved through conjugation.
- Ohtsu, Hironori,Nakanishi, Yuka,Bastow, Kenneth F.,Lee, Fang-Yu,Lee, Kuo-Hsiung
-
p. 1851 - 1857
(2007/10/03)
-